Re: Zenith website undergoing changes

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith website undergoing changes

in response to

Re: Zenith website undergoing changes

Hartland

posted on Mar 03, 2016 02:25PM

Hartland,

I haven't heard anything regarding the Zenith presentation at the BIOTECanada Investor Summit other than Sarah confirming that Zenith was presenting. Regarding the reorganization and prostate trial, this is the latest info Sarah emailed me a couple weeks ago: "The company has decided to close the Zenith reorganization after the clinical trial has commenced to avoid any delay to the launch of the trial."